{"disease":{"id":"induction","name":"induction"},"drugs":{"marketed":[{"drug_id":"daratumumab-and-hyaluronidase-fihj","indication_name":"Multiple Myeloma - Induction/Consolidation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Darzalex Faspro","generic_name":"daratumumab-and-hyaluronidase-fihj","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"CD38","drug_class":"CD38-directed Cytolytic Antibody [EPC]","quality_score":63,"revenue":null,"mechanism":"Daratumumab and Hyaluronidase-fihj is a monoclonal antibody that targets CD38, a transmembrane glycoprotein on the surface of hematopoietic cells."},{"drug_id":"sevoflurane","indication_name":"Induction and maintenance of general anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SEVOFLURANE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"General Anesthetic [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"sevoflurane","indication_name":"Induction and maintenance of general anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SEVOFLURANE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"General Anesthetic [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"daunorubicin-hydrochloride","indication_name":"Remission induction in pediatric and adult acute lymphocytic leukemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DAUNORUBICIN HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"daunorubicin-hydrochloride","indication_name":"Remission induction in adult acute nonlymphocytic leukemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DAUNORUBICIN HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl526","indication_name":"Induction of General Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PROPOFOL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"General Anesthetic [EPC]","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"clomifene","indication_name":"Induction of spermatogenesis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Clomid","generic_name":"clomifene","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase","drug_class":"Estrogen Agonist/Antagonist","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"clomifene","indication_name":"Ovulation induction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Clomid","generic_name":"clomifene","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase","drug_class":"Estrogen Agonist/Antagonist","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"oxytocin","indication_name":"Induction of labor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Oxytocin 5 Usp Units In Dextrose 5%","generic_name":"OXYTOCIN","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Oxytocin receptor","drug_class":"Adrenocorticotropic Hormone [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"dinoprost","indication_name":"Induction of labor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Enzaprost","generic_name":"DINOPROST","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Prostaglandin F2-alpha receptor","drug_class":"dinoprost","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ganirelix","indication_name":"Ovulation induction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ganirelix Acetate","generic_name":"GANIRELIX","company_name":"Organon Usa Organon","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"Gonadotropin Releasing Hormone Receptor Antagonist","quality_score":46,"revenue":null,"mechanism":""},{"drug_id":"progesterone-plus-hcg","indication_name":"Induction of labor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Progesterone","generic_name":"Progesterone plus HCG","company_name":"Dunamenti REK Istenhegyi IVF Center","drug_phase":"marketed","molecular_target":"progesterone receptor, luteinizing hormone/choriogonadotropin receptor","drug_class":"Progesterone [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"metformin","indication_name":"Induction of ovulation in polycystic ovarian syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Glucophage","generic_name":"metformin","company_name":"Generic (originally Merck Serono/Lipha)","drug_phase":"marketed","molecular_target":"5'-AMP-activated protein kinase subunit beta-1, Solute carrier family 22 member 1, Solute carrier family 22 member 2","drug_class":"Dipeptidyl Peptidase 4 Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Activates AMP-activated protein kinase (AMPK) to reduce hepatic glucose production and improve insulin sensitivity without causing hypoglycemia."},{"drug_id":"follitropin","indication_name":"Ovulation induction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Urofollitropin","generic_name":"FOLLITROPIN","company_name":"Serono","drug_phase":"marketed","molecular_target":"Follicle-stimulating hormone receptor","drug_class":"Gonadotropin [EPC]","quality_score":10,"revenue":null,"mechanism":"FOLLITROPIN works by mimicking the action of follicle-stimulating hormone to stimulate follicle growth and ovulation."},{"drug_id":"buserelin","indication_name":"Induction of final follicular maturation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Receptal","generic_name":"BUSERELIN","company_name":"Sanofi K.K.","drug_phase":"marketed","molecular_target":"Gonadotropin-releasing hormone receptor","drug_class":"buserelin","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"clomid","indication_name":"Induction of spermatogenesis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Clomid","company_name":"rana alaaeldin aly ibrahim nasr","drug_phase":"phase_1","molecular_target":"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase, 5-hydroxytryptamine receptor 6, Adenosine receptor A3","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"clomid","indication_name":"Ovulation induction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Clomid","company_name":"rana alaaeldin aly ibrahim nasr","drug_phase":"phase_1","molecular_target":"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase, 5-hydroxytryptamine receptor 6, Adenosine receptor A3","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"etrasimod","indication_name":"Induction of remission in adults with moderately to severely active ulcerative colitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Etrasimod","generic_name":"etrasimod","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Sphingosine 1-phosphate (S1P) receptors 1, 4, and 5","drug_class":"Sphingosine 1-phosphate receptor modulator","quality_score":64,"revenue":null,"mechanism":"Etrasimod is an S1P receptor modulator that blocks lymphocyte egress from lymphoid organs, reducing peripheral blood lymphocytes."},{"drug_id":"etrasimod","indication_name":"Induction of clinical remission in adults with moderately to severely active Crohn's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Etrasimod","generic_name":"etrasimod","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Sphingosine 1-phosphate (S1P) receptors 1, 4, and 5","drug_class":"Sphingosine 1-phosphate receptor modulator","quality_score":64,"revenue":null,"mechanism":"Etrasimod is an S1P receptor modulator that blocks lymphocyte egress from lymphoid organs, reducing peripheral blood lymphocytes."},{"drug_id":"glucophage","indication_name":"Induction of ovulation in polycystic ovarian syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Glucophage","company_name":"Dr. Reddy's Laboratories Limited","drug_phase":"marketed","molecular_target":"5'-AMP-activated protein kinase subunit beta-1, Solute carrier family 22 member 1, Solute carrier family 22 member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"velsipity","indication_name":"Induction of remission in adults with moderately to severely active ulcerative colitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Velsipity","generic_name":"Etrasimod Arginine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Sphingosine 1-phosphate (S1P) receptors 1, 4, and 5","drug_class":"Sphingosine 1-phosphate receptor modulator","quality_score":67,"revenue":null,"mechanism":"Etrasimod binds S1P receptors 1, 4, and 5, blocking lymphocyte egress from lymphoid organs."},{"drug_id":"velsipity","indication_name":"Induction of clinical remission in adults with moderately to severely active Crohn's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Velsipity","generic_name":"Etrasimod Arginine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Sphingosine 1-phosphate (S1P) receptors 1, 4, and 5","drug_class":"Sphingosine 1-phosphate receptor modulator","quality_score":67,"revenue":null,"mechanism":"Etrasimod binds S1P receptors 1, 4, and 5, blocking lymphocyte egress from lymphoid organs."},{"drug_id":"flutoprazepam","indication_name":"Induction of general anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Restas","generic_name":"FLUTOPRAZEPAM","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"flutoprazepam","quality_score":null,"revenue":null,"mechanism":"Flutoprazepam works by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain."},{"drug_id":"femara","indication_name":"Induction of ovulation in polycystic ovarian syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Femara","company_name":"M.D. Anderson Cancer Center","drug_phase":"discontinued","molecular_target":"Cytochrome P450 11B2, mitochondrial, Aromatase, Cytochrome P450 11B1, mitochondrial","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"femara","indication_name":"Induction of ovulation in unexplained infertility","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Femara","company_name":"M.D. Anderson Cancer Center","drug_phase":"discontinued","molecular_target":"Cytochrome P450 11B2, mitochondrial, Aromatase, Cytochrome P450 11B1, mitochondrial","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"letrozole","indication_name":"Induction of ovulation in polycystic ovarian syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Femara","generic_name":"letrozole","company_name":"Novartis AG","drug_phase":"marketed","molecular_target":"aromatase enzyme","drug_class":"Aromatase Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":"Letrozole reduces estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogens."},{"drug_id":"letrozole","indication_name":"Induction of ovulation in unexplained infertility","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Femara","generic_name":"letrozole","company_name":"Novartis AG","drug_phase":"marketed","molecular_target":"aromatase enzyme","drug_class":"Aromatase Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":"Letrozole reduces estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogens."},{"drug_id":"daratumumab-and-hyaluronidase-fihj","indication_name":"Multiple Myeloma in combination with bortezomib, lenalidomide, and dexamethasone for induction and consolidation in newly diagnosed patients who are eligible for autologous stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Darzalex Faspro","generic_name":"daratumumab-and-hyaluronidase-fihj","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"CD38","drug_class":"CD38-directed Cytolytic Antibody [EPC]","quality_score":63,"revenue":null,"mechanism":"Daratumumab and Hyaluronidase-fihj is a monoclonal antibody that targets CD38, a transmembrane glycoprotein on the surface of hematopoietic cells."},{"drug_id":"dinoprostone","indication_name":"Induction of labor","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prepidil","generic_name":"DINOPROSTONE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Prostaglandin E2 receptor EP4 subtype","drug_class":"Prostaglandin Analog [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"amidate","indication_name":"Induction of general anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amidate","generic_name":"Etomidate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-2/beta-2/gamma-2","drug_class":"General Anesthetic [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"corifollitropin-alfa","indication_name":"Ovulation induction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Org 36286","generic_name":"CORIFOLLITROPIN ALFA","company_name":"Merck Sharp & Dohme Limited","drug_phase":"marketed","molecular_target":"Follicle-stimulating hormone receptor","drug_class":"","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"chorionic-gonadotrophin","indication_name":"Induction of final follicular maturation and luteinization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Choriogonadotropin","generic_name":"chorionic gonadotrophin","company_name":"Ferring","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"chorionic-gonadotrophin","indication_name":"Induction of ovulation and pregnancy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Choriogonadotropin","generic_name":"chorionic gonadotrophin","company_name":"Ferring","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"elonva","indication_name":"Ovulation induction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Elonva","company_name":"University Medical Centre Ljubljana","drug_phase":"marketed","molecular_target":"Follicle-stimulating hormone receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":34,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07080086","title":"The Effect of Preoperative Biological Age on Hemodynamics and Renal Function","phase":"","overall_status":"COMPLETED","enrollment_count":268833,"lead_sponsor_name":"Nanjing First Hospital, Nanjing Medical University","has_results":false},{"nct_id":"NCT06105346","title":"Prevalence of ENT Diseseas","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Medical University of Graz","has_results":false},{"nct_id":"NCT04312425","title":"Classic and Modified Rapid Sequence Induction for Prevention of Gastric Content Regurgitation","phase":"","overall_status":"COMPLETED","enrollment_count":8601,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT05671783","title":"Intraoperative Hypotension and Post-anesthesia Care Unit Recovery","phase":"","overall_status":"COMPLETED","enrollment_count":4776,"lead_sponsor_name":"Acibadem University","has_results":false},{"nct_id":"NCT04350437","title":"Induction Of Labor: Predictors of Outcomes","phase":"NA","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05775029","title":"RSI Observation Follow-up","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2300,"lead_sponsor_name":"Jakob Zeuchner","has_results":false},{"nct_id":"NCT05759988","title":"Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)","phase":"NA","overall_status":"RECRUITING","enrollment_count":2300,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT05884918","title":"Intraoperative Hypotension in High-risk Patients Undergoing Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Mazovia Regional Hospital in Siedlce","has_results":false},{"nct_id":"NCT03694860","title":"Rapid Sequence Induction EU: Electronic Survey (RSIEU)","phase":"","overall_status":"COMPLETED","enrollment_count":1921,"lead_sponsor_name":"Brno University Hospital","has_results":false},{"nct_id":"NCT02751684","title":"EUROpE-RSI (EURopean Online Evaluation RSI Study)","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Universitätsklinikum Köln","has_results":false},{"nct_id":"NCT06733129","title":"Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1218,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT03787732","title":"Preventing Cardiovascular Collapse With Administration of Fluid Resuscitation During Induction and Intubation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1067,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT04527757","title":"Duration of Anaesthesia Induction in Paediatric Patients: Prospective Observational Trial","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Brno University Hospital","has_results":false},{"nct_id":"NCT05246761","title":"Balloon Catheter Combined With Oxytocin Induction Among the Pregnant Women With Previous Cesarean Section","phase":"","overall_status":"UNKNOWN","enrollment_count":924,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT04536753","title":"The Utility of Customised Growth Charts for Identifying Macrosomia and the Effect of Intervention","phase":"","overall_status":"COMPLETED","enrollment_count":845,"lead_sponsor_name":"Newcastle University","has_results":false},{"nct_id":"NCT05056467","title":"Labor Induction in Preeclampsia High-risk Women","phase":"NA","overall_status":"UNKNOWN","enrollment_count":825,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04220320","title":"The Success of Labor Induction Based on a Modified BISHOP Score.","phase":"","overall_status":"COMPLETED","enrollment_count":758,"lead_sponsor_name":"Rambam Health Care Campus","has_results":false},{"nct_id":"NCT05505799","title":"Community Medical Center, Continuous Quality Improvement Project, Rapid Sequence Intubation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"Community Medical Center, Toms River, NJ","has_results":false},{"nct_id":"NCT03001661","title":"An RCT of a Synthetic Osmotic Cervical Dilator for Induction of Labour in Comparison to Dinoprostone Vaginal insErt","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":674,"lead_sponsor_name":"Birmingham Women's NHS Foundation Trust","has_results":false},{"nct_id":"NCT06934785","title":"LE + CC vs. LE for Ovulation Induction","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Mỹ Đức Hospital","has_results":false},{"nct_id":"NCT04747301","title":"DOuble-BAlloon Versus PROstaglandin E2 for Cervical Ripening in Low Risk Pregnancies","phase":"NA","overall_status":"UNKNOWN","enrollment_count":540,"lead_sponsor_name":"Hanoi Obstetrics and Gynecology Hospital","has_results":false},{"nct_id":"NCT05333731","title":"Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes","phase":"","overall_status":"UNKNOWN","enrollment_count":528,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT03749902","title":"A Randomized Trial of Oral Misoprostol Alone Versus Oral Misoprostol Followed by Oxytocin for Labour Induction","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":520,"lead_sponsor_name":"University of Liverpool","has_results":false},{"nct_id":"NCT03489928","title":"Misoprostol Labour Induction Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":511,"lead_sponsor_name":"David Young","has_results":false},{"nct_id":"NCT04887493","title":"To Study the Efficacy and Safety of Misoprostol by Sublingual Routes for Induction of Labour","phase":"NA","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Ministry of Health, Bhutan","has_results":false},{"nct_id":"NCT06187779","title":"Induction ATAD Catheter and Lower Segment Thickness","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT07589075","title":"Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Beni-Suef University","has_results":false},{"nct_id":"NCT04492150","title":"Effect of Glucose 5% on Labor Length","phase":"NA","overall_status":"UNKNOWN","enrollment_count":476,"lead_sponsor_name":"Suez Canal University","has_results":false},{"nct_id":"NCT02825641","title":"Premature Rupture of Membranes With a Bishop Score<6: Comparison of Medical Induction/Expectant Management","phase":"NA","overall_status":"COMPLETED","enrollment_count":458,"lead_sponsor_name":"Rambam Health Care Campus","has_results":false},{"nct_id":"NCT04268914","title":"Virtual Reality to Reduce Pre-Operative Anxiety","phase":"NA","overall_status":"SUSPENDED","enrollment_count":450,"lead_sponsor_name":"Children's Hospital Los Angeles","has_results":false},{"nct_id":"NCT04384627","title":"Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":445,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05969886","title":"Ventricular-Arterial Coupling: A Predictor of Post-Induction Hypotension","phase":"","overall_status":"COMPLETED","enrollment_count":405,"lead_sponsor_name":"University Medical Center Ho Chi Minh City (UMC)","has_results":false},{"nct_id":"NCT04066478","title":"Does DHEA IVF Outcomes in Poor Responders?","phase":"PHASE2, PHASE3","overall_status":"SUSPENDED","enrollment_count":400,"lead_sponsor_name":"Homerton University Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT06249815","title":"Sequential Use of Foley's Catheter and Misoprostol Versus Misoprostol Alone for Induction of Labour: a Multicentre Randomised Controlled Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Kazakhstan's Medical University \"KSPH\"","has_results":false},{"nct_id":"NCT04325256","title":"Accuracy of Different Scoring Systems for Predicting Successful Induction of Labor","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06591247","title":"Membrane Stripping for Cervical Ripening","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT06736197","title":"An Algorithmic Approach to Preoxygenation","phase":"NA","overall_status":"COMPLETED","enrollment_count":378,"lead_sponsor_name":"Pamukkale University","has_results":false},{"nct_id":"NCT06983535","title":"Comparing Outpatient and Inpatient Use of a Cervical Balloon for Starting Labor in Low-Risk Pregnancies.","phase":"NA","overall_status":"TERMINATED","enrollment_count":358,"lead_sponsor_name":"Ziekenhuis Oost-Limburg","has_results":false},{"nct_id":"NCT06268431","title":"Oxytocin Rest to Reduce Cesarean Delivery","phase":"NA","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"Christiana Care Health Services","has_results":false},{"nct_id":"NCT03430804","title":"Transvaginal Sonographic Measurement of Cervical Length Versus Bishop Score in Induction of Labour for Prediction of Caesarean Delivery.","phase":"","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT03489798","title":"Comparison of Two Protocols of Misoprostol (PGE1) and the Rate of Cesarean Section Due to Failed Induction.","phase":"NA","overall_status":"COMPLETED","enrollment_count":310,"lead_sponsor_name":"Saint Thomas Hospital, Panama","has_results":false},{"nct_id":"NCT06960850","title":"Effects of Oral Propranolol on Induction-Delivery Interval During Induction of Labour With Oxytocin","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":308,"lead_sponsor_name":"Federal Teaching Hospital Abakaliki","has_results":false},{"nct_id":"NCT05144048","title":"Outpatient Induction of Labor With Oral Misoprostol","phase":"NA","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Sorlandet Hospital HF","has_results":false},{"nct_id":"NCT06685991","title":"Effect of Timing of Dexamethasone During Induction on Postoperative Outcomes","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"AABDI Mohammed","has_results":false},{"nct_id":"NCT06773351","title":"A Response Surface Analysis for the Interaction Between Ciprofol and Sevoflurane","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Feng Gao","has_results":false},{"nct_id":"NCT04485819","title":"Optimal Embryonic Stage for Transfer in Poor Responders","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Ganin Fertility Center","has_results":false},{"nct_id":"NCT03748147","title":"Cervical Ripening in Obese Women: Efficacy of 25 mcg Versus 50 mcg of Misoprostol","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"University of Cincinnati","has_results":false},{"nct_id":"NCT03742531","title":"Does Induction Dosage in Latent Phase Affect Active Phase of Labor?","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Zeynep Kamil Maternity and Pediatric Research and Training Hospital","has_results":false},{"nct_id":"NCT06056141","title":"Induction of Labour at Term With Low Dose Oral Misoprostol Versus a Foley Catheter","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Kazakhstan's Medical University \"KSPH\"","has_results":false},{"nct_id":"NCT04477226","title":"Transvaginal Ultrasound As Predictors of Successful Induction of Labour","phase":"","overall_status":"COMPLETED","enrollment_count":294,"lead_sponsor_name":"Universiti Kebangsaan Malaysia Medical Centre","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}